Estimating the duration of pertussis immunity using epidemiological signatures

PLoS Pathogens

Volumn 5, Issue 10, 2009, Pages

  Wearing, Helen J ^a   Rohani, Pejman ^b,c,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; CHILD; CONTROLLED STUDY; EPIDEMIC; HUMAN; INCIDENCE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NEWBORN; PERTUSSIS; PREDICTION; PRESCHOOL CHILD; SENSITIVITY ANALYSIS; UNITED KINGDOM; VACCINATION; ALGORITHM; BIOLOGICAL MODEL; BORDETELLA PERTUSSIS; DISEASE TRANSMISSION; IMMUNOLOGY;

ALGORITHMS; BORDETELLA PERTUSSIS; DISEASE OUTBREAKS; ENGLAND; HUMANS; MODELS, IMMUNOLOGICAL; PERTUSSIS VACCINE; WALES; WHOOPING COUGH;

EID: 73649108609     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000647     Document Type: Article

References (42)

1. Creighton C (1894) A History of Epidemics in Britain. Cambridge: Cambridge University Press.
2. Crowcroft NS, Stein C, Duclos P, Birmingham M (2003) How best to estimate the global burden of pertussis? Lancet Infectious Diseases 3: 413-418.
3. CDC (2002) Pertussis: United States, 1997-2000. MMWR 51: 73-76.
4. Skowronski DM, De Serres G, MacDonald D, et al. (2002) The changing age and seasonal profile of pertussis in Canada. Journal of Infectious Diseases 185: 1448-1453.
5. Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, et al. (1998) Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatric Infectious Disease Journal 17: 412-418.
6. de Melker HE, Conyn-van Spaendonck MA, Rümke HC, van Wijngaarden JK, Mooi FR, et al. (1997) Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infectious Diseases 3: 175-178.
7. Cherry JD (1998) Pertussis in adults. Annals of Internal Medicine 128: 64-66.
8. Srugo I, Benilevi D, Madeb R, et al. (2000) Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerging Infectious Diseases 6: 526-529.
9. Greenberg DP (2005) Pertussis in adolescents. Increasing incidence brings attention to the need for booster immunization of adolescents. Pediatric Infectious Disease Journal 24: 721-728.
10. Steele RW (2004) Pertussis: is eradication achievable? Pediatric Annals 33: 525-534.
11. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ (1995) Pertussis in adults: frequency of transmission after household exposure. The Lancet 346: 1326-1329.
12. Versteegh FGA, Schellekens JFP, Nagelkerke AF, Roord JJ (2002) Laboratoryconfirmed reinfections with Bordetella pertussis. Acta Paediatrica 91: 95-99.
13. Broutin H, Rohani P, Guégan JF, Grenfell BT, Simondon F (2004) Loss of immunity to pertussis in a rural community in Senegal. Vaccine 22: 594-596.
14. Laing JS, Hay M (1902) Whooping-cough: its prevalence and mortality in Aberdeen. Public Health 14: 584-598.
15. Gordon JE, Hood RI (1951) Whooping cough and its epidemiological anomalies. American Journal of Medical Science 222: 333-361.
16. Cherry JD, Gornbein J, Heininger U, Stehr K (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16: 1901-1906.
17. Storsaeter J, Hallander HO, Gustafsson L, Olin P (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16: 1907-1916.
18. de Melker HE, Versteegh FGA, Conyn-van Spaendonck MAE, Elvers LH, Berbers GAM, et al. (2000) Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. Journal of Clinical Microbiology 38: 800-806.
19. Mills KHG (2001) Immunity to Bordetella pertussis. Microbes and Infection 3: 655-677.
20. Leef M, Elkins KL, Barbic J, Shahin RD (2000) Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. Journal of Experimental Medicine 191: 1841-1852.
21. Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 24: S58-S61.
22. Grenfell BT, Anderson RM (1989) Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proceedings of the Royal Society of London Series B - Biological Sciences 236: 213-252.
23. Hethcote HW (1997) An age-structured model for pertussis transmission. Mathematical Biosciences 145: 89-136.
24. van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M (2000) Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in the Netherlands. Mathematical Biosciences 164: 161-182.
25. Águas R, Gonçalves G, Gomes MGM (2006) Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infectious Diseases 6: 112-117.
26. Rohani P, Earn DJD, Grenfell BT (1999) Opposite patterns of synchrony in sympatric disease metapopulations. Science 286: 968-971.
27. Gillespie DT (1977) Exact stochastic simulation of coupled chemical reactions. Journal of Physical Chemistry 81: 2340-2361.
28. Gillespie DT (2001) Approximate accelerated stochastic simulation of chemically reacting systems. Journal of Chemical Physics 115: 1716-1733.
29. Keeling MJ, Rohani P (2007) Modeling Infectious Diseases. Princeton: Princeton University Press.
30. Behrman RE, Kliegman RM (1998) Nelson Essentials of Pediatrics. Philadelphia: Saunders.
31. Anderson RM, May RM (1982) Directly transmitted infectious diseases: control by vaccination. Science 215: 1053-1060.
32. Clarkson JA, Fine PEM (1985) The efficiency of measles and pertussis notification in England and Wales. International Journal of Epidemiology 14: 153-168.
33. Anderson RM, Grenfell BT, May RM (1984) Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. Journal of Hygiene, Cambridge 93: 587-608.
34. Rohani P, Earn DJD, Grenfell BT (2000) Impact of immunisation on pertussis transmission in England and Wales. The Lancet 355: 285-286.
35. Crowcroft NS, Pebody RG (2006) Recent developments in pertussis. The Lancet 367: 1926-1936.
36. McLean AR, Blower SM (1993) Imperfect vaccines and herd immunity to HIV. Proceedings of the Royal Society of London Series B - Biological Sciences 253: 9-13.
37. Gandon S, Mackinnon S, Nee S, Read A (2003) Imperfect vaccination: some epidemiological and evolutionary consequences. Proceedings of the Royal Society of London Series B - Biological Sciences 270: 1129-1136.
38. Alexander ME, Moghadas SM, Rohani P, Summers AR (2006) Modelling the effect of a booster vaccination on disease epidemiology. Journal of Mathematical Biology 52: 290-306.
39. Heffernan JM, Keeling MJ (2009) Implications of vaccination and waning immunity. Proceedings of the Royal Society of London Series B - Biological Sciences 276: 2071-2080.
40. Fine PEM, Clarkson JA (1986) Seasonal influences on pertussis. International Journal of Epidemiology 15: 237-247.
41. Schenzle D (1984) An age-structured model of pre- and post-vaccination measles transmission. IMA Journal of Mathematics Applied in Medicine and Biology 1: 169-191.
42. Nguyen HTH, Rohani P (2007) Noise, nonlinearity and seasonality: the epidemics of whooping cough revisited. Journal of the Royal Society Interface 5: 403-413.